Tag: Genentech

Update on Genentech’s Tecentriq Plus Avastin

South San Francisco, CA  April 18, 2023 Press Release Genentech’s Tecentriq Plus Avastin Reduced the Risk of Cancer Returning in People With Certain Types of Adjuvant Liver Cancer in a Phase III Study   In the first-ever positive Phase III…